Boston Scientific Corporation

BSX
Errichiello v. Boston Scientific Corp., et al., No. 1:20-cv-12225 (D. Mass.)

On November 17, 2020, Boston Scientific Corporation(NYSE: BSX) stunned the markets when it announced that it had “initiated a global, voluntary recall of the unused inventory of the LOTUS Edge Aortic Valve System due to complexities associated with the product.” The Company further stated that it “has chosen to retire the entire LOTUS product platform immediately,” and that it expected to record $225 to $300 million in pre-tax GAAP charges as a result of this decision. BSX shares fell approximately 8% on heavier than usual volume, representing billions of dollars in lost market capitalization.

Lead Plaintiff deadline
February 2, 2021
class period
April 24, 2019
to
November 16, 2020
Case Documents
No documents available. Contact us if you need a case document.